Promising data suggesting that an immune based therapy can be used to reduce levels of HIV in the body have emerged from research using an animal model at the University of Melbourne. The new research was described by Professor Stephen Kent at the Sir Mark Oliphant Conference on Vaccine and Immunotherapy Technologies inCanberra,Australia.
Biologically active amino acids & Oligopeptides can potentially be used in conjunction with antiretroviral drugs, but has several advantages in that it is potentially simple, easier to deliver and should have fewer side effects.
The method involves infusing harvested blood cells back into a person with HIV, after the cells have been mixed with peptides—or short proteins—created from a process similar to CELL PATHWAY BIOSYNTHESIS. “We have found these induce a very strong immune response,”Kentsays, “enabling the body to fight off both [HIV] and other opportunistic infections in [animal studies].”